Nutranomics (NNRX) 10-Q 22 Dec 14 2015 Q1 Quarterly report Financial data

Document_and_Entity_Informatio

Document and Entity Information	3 Months Ended
	Oct. 31, 2014	Dec. 19, 2014
Document And Entity Information [Abstract]
Entity Registrant Name	NUTRANOMICS, INC.
Entity Central Index Key	1451433
Trading Symbol	nnrx
Current Fiscal Year End Date	-24
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		55,996,698
Document Type	10-Q
Document Period End Date	31-Oct-14
Amendment Flag	FALSE
Document Fiscal Year Focus	2015
Document Fiscal Period Focus	Q1

Consolidated_Balance_Sheets

Consolidated Balance Sheets (USD $)	Oct. 31, 2014	Jul. 31, 2014
CURRENT ASSETS
Cash and cash equivalents	$83,084	$79,235
Accounts receivable, net of allowance	231,071	152,879
Prepaid expenses	81	4,516
Other current assets	1,279	23,254
Inventory	151,063	271,941
Total Current Assets	466,578	531,825
PROPERTY & EQUIPMENT, net	13,832	16,355
OTHER ASSETS
Rent deposit	2,000	2,000
Total Assets	482,410	550,180
CURRENT LIABILITIES
Accounts payable and accrued expenses	470,772	518,890
Lines of credit	29,887	33,098
Convertible notes payable-current portion	546,658	58,999
Loan payable-current portion	52,426	51,071
Note Derivative Liability	139,409	177,907
Related party payable	20,109	21,083
Related party notes payable	35,036	36,608
Unearned revenue	262,084	338,263
Total Current Liabilities	1,556,381	1,235,919
LONG-TERM LIABILITIES
Convertible notes payable	70,479	525,000
Loan payable	148,805	157,830
Total Liabilities	1,775,665	1,918,749
STOCKHOLDERS' DEFICIT
Common stock; par value of $.001, 750,000,000 shares authorized; 54,023,354 and 51,151,766 shares issued and outstanding at October 31, 2014 and July 31, 2014, respectively	54,025	51,153
Additional paid in capital	3,449,509	3,337,911
Accumulated deficit	-4,796,789	-4,757,633
Total Stockholders' Deficit	-1,293,255	-1,368,569
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	$482,410	$550,180

Consolidated_Balance_Sheets_Pa

Consolidated Balance Sheets (Parentheticals) (USD $)	Oct. 31, 2014	Jul. 31, 2014
Statement of Financial Position [Abstract]
Common stock, par value (in dollars per share)	$0.00	$0.00
Common stock, shares authorized	750,000,000	750,000,000
Common stock, shares issued	54,023,354	51,151,766
Common stock, shares outstanding	54,023,354	51,151,766

Consolidated_Statements_of_Ope

Consolidated Statements of Operations (Unaudited) (USD $)	3 Months Ended
	Oct. 31, 2014	Oct. 31, 2013
Income Statement [Abstract]
REVENUES	$641,237	$793,496
COST OF SALES	299,670	636,540
Gross profit	341,567	156,956
OPERATING EXPENSES
General and administrative	63,785	85,981
Advertising and marketing	24,771	27,042
Professional fees	59,269	137,932
Research and development		31,617
Salaries and wages	142,307	94,575
Total Operating Expenses	290,132	377,147
OPERATING (LOSS)	51,435	-220,191
OTHER INCOME (EXPENSE)
Interest expense	-90,591	-8,505
Total Other Income (Expense)	-90,591	-8,505
NET (LOSS) BEFORE INCOME TAXES	-39,156	-228,696
Provision for income taxes
NET (LOSS)	($39,156)	($228,696)
BASIC AND DILUTED LOSS PER SHARE (in dollars per share)	$0	($0.01)
WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING (in shares)	52,321,884	36,457,164

Condensed_Consolidated_Stateme

Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $)	3 Months Ended
	Oct. 31, 2014	Oct. 31, 2013
OPERATING ACTIVITIES
Net (Loss)	($39,156)	($228,696)
Adjustments to reconcile net (loss) to net cash from operating activities:
Allowance for bad debt		-5,632
Gain (loss) on derivative
Amortization of debt discount	75,138
Short-term loan issued for professional fees
Depreciation expense	2,523	1,876
Share based compensation-common stock
Changes in operating assets and liabilities:
Accounts receivable	-78,192	-26,700
Other assets	26,410	-501
Inventory	120,878	-20,070
Deferred revenue	-76,179	83,889
Accounts payable and accrued expenses	-52,136	123,035
Net Cash (Used) From Operating Activities	-20,714	-72,799
INVESTING ACTIVITIES
Purchase of equipment
Net Cash (Used) Investing Activities
FINANCING ACTIVITIES
Proceeds from related party payable
Repayments of related party payable	-974	-825
Proceeds from convertible debt		375,000
Repayment of loan payable	-7,670	-7,321
Proceeds from line of credit	-3,211	6,000
Repayment of line of credit		-810
Repayments of notes payable- related party	-1,572
Sale of common stock	37,990	-1,374
Net Cash (Used) From Financing Activities	24,563	370,670
Net Increase (Decrease) in Cash and Cash Equivalents	3,849	297,871
Cash and Cash Equivalents, Beginning of Period	79,235	11,129
Cash and Cash Equivalents, End of Period	83,084	309,000
Cash paid during the period for:
Interest	3,208	1,811
Income Taxes
Non-cash Investing and Financing activities:
Stock issued for conversion of Note	42,000
Conversion of derivative feature	$34,480

ORGANIZATION_AND_BASIS_OF_PRES

ORGANIZATION AND BASIS OF PRESENTATION	3 Months Ended
	Oct. 31, 2014
Organization And Basis Of Presentation [Abstract]
ORGANIZATION AND BASIS OF PRESENTATION	NOTE 1 – ORGANIZATION AND BASIS OF PRESENTATION
	The condensed consolidated unaudited interim financial statements included herein have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission ("SEC"). The condensed consolidated financial statements and notes are presented as permitted on Form 10-Q and do not contain information included in the Company's annual statements and notes. Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted pursuant to such rules and regulations, although the Company believes that the disclosures are adequate to make the information presented not misleading. It is suggested that these condensed consolidated financial statements be read in conjunction with the July 31, 2014 audited consolidated financial statements and the accompanying notes thereto. The results of operations for the interim periods are not necessarily indicative of the results to be expected for the full year. The preparation of financial statements in accordance with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the Company's consolidated condensed financial statements and accompanying notes. Actual results could differ materially from those estimates.
	These condensed consolidated unaudited financial statements reflect all adjustments, including normal recurring adjustments which, in the opinion of management, are necessary to present fairly the operations and cash flows for the periods presented.
	Health Education Corporation d.b.a. NutraNomics, Inc., (the "Company") was incorporated under the laws of the State of Delaware on February 14, 1996, and later reincorporated under the laws of the State of Utah on January 5, 1998. The Company was originally organized to provide education services, books, cassette tapes and public presentations. The Company utilized several revenue generating tools in order to accomplish this goal including Live Blood Analysis, iridology, bone density screening and other self-help methods. In 1998, the Company changed its incorporation to the State of Utah, the primary place of business. In 2001, the Company created its own line of nutritional products that quickly became its leading revenue source. The Company filed for the d.b.a. of NutraNomics, Inc., in order to fully prepare and utilize the brand name for expansion. In retail outlets and to its clientele, the Company is known as NutraNomics, Inc. The Company sells its own brand of supplements in 16 countries direct to the public. The Company also performs research and development services and outsource manufacturing for third party entities. Beyond its sales in both the United States and Canada, the Company maintains sales representatives in Taiwan, Japan, Singapore, Philippines, Malaysia and South Korea. The Company maintains multiple different trademarks, trade names and patents.
	Merger
	On September 13, 2013, Buka Ventures, Inc., a Nevada corporation ("Buka") and Health Education Corporation dba. Nutranomics, Inc., a Utah corporation ("Nutranomics"), executed and delivered a Share Exchange Agreement (the "Share Agreement") and all required or necessary documentation to complete a merger (collectively, the "Transaction Documents"), whereby Buka became the parent company and Nutranomics became the wholly-owned subsidiary on the closing of the Share Agreement. Prior to the closing of this transaction and pursuant to a certain Share Exchange Agreement dated September 13, 2013, Buka canceled 25,000,000 of its 46,500,000 issued and outstanding common shares and simultaneously issued 25,005,544 shares of its common stock in exchange for 8,994,800 shares of Nutranomics common stock. The merger has been treated as a reverse acquisition and a recapitalization of a public company. Accordingly, the historic financial statements of the Company are the historic financial statements of Nutranomics, which was incorporated on January 5, 1998.

SUMMARY_OF_SIGNIFICANT_ACCOUNT

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	3 Months Ended
	Oct. 31, 2014
Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
	Loss per Share
	Basic loss per share ("EPS") is computed by dividing net loss (the numerator) by the weighted-average number of common shares outstanding for the period (the denominator). Diluted EPS is computed by dividing net loss by the weighted-average number of common shares and potential common shares outstanding (if dilutive) during each period. Potential common shares include common shares to be issued related to convertible debentures and stock pending issue under the ratchet provision.
	As the Company has incurred losses for the three months ended October 31, 2014 and 2013, the potentially dilutive shares are anti-dilutive and are thus not added into the loss per share calculations.
	Going Concern
	The Company's financial statements are prepared using generally accepted accounting principles applicable to a going concern that contemplates the realization of assets and liquidation of liabilities in the normal course of business. The Company has generally had net losses after consideration of income taxes. Further, the Company has negative working capital and insufficient cash flows from operation as of October 31, 2014, and does not have the requisite liquidity to pay its current obligations. These factors, among others, raise substantial doubt about its ability to continue as a going concern. Management will seek to increase revenues and reduce costs, while raising capital through the sale of its stock. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.
	Use of Estimates
	The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America ("US GAAP") requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. These estimates and assumptions are based on management's best estimates and judgment. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the economic environment, which management believes to be reasonable under the circumstances. Management adjusts such estimates and assumptions when facts and circumstances dictate. As future events and their effects cannot be determined with precision, actual results could differ from those estimates.
	Derivative Liabilities
	In connection with the private placement of certain convertible notes beginning in January 2014, the Company became contingently obligated to issue shares of common stock in excess of the 750 million authorized under the Company's certificate of incorporation. Consequently, the ability to settle these obligations with common shares would be unavailable causing these obligations to potentially be settled in cash. This condition creates a derivative liability.
	The Company has a sequencing policy regarding share settlement wherein instruments with the earliest issuance date would be settled first. The sequencing policy also considers contingently issuable additional shares, such as those issuable upon a stock split, to have an issuance date to coincide with the event giving rise to the additional shares.
	Using this sequencing policy, all instruments convertible into common stock, including warrants and the conversion feature of notes payable, issued subsequent to January 14, 2014 are derivative liabilities.
	The Company values these convertible notes payable using the multinomial lattice method that values the derivative liability within the notes based on a probability weighted discounted cash flow model. The resulting liability is valued at each reporting date and the change in the liability is reflected as change in derivative liability in the statement of operations.
	Revenue Recognition
	Our revenue is derived from the service revenue from Live Blood Analysis, sale of retail products, and revenue derived from educational services.
	The Company's revenue recognition policy is in accordance with the requirements of Staff Accounting Bulletin ("SAB") No. 104, Revenue Recognition ("SAB 104"), and other applicable revenue recognition guidance under US GAAP. Sales revenue is recognized for our retail and wholesale customers when: (i) persuasive evidence of a sales arrangement exists, (ii) the sales terms are fixed or determinable, (iii) title and risk of loss have transferred, and (iv) collectability is reasonably assured — generally when products are shipped to the customer and services are rendered, except in situations in which title passes upon receipt of the products by the customer. In this case, revenues are recognized upon notification that customer receipt has occurred. The Company accrues an estimated amount for sales returns and allowances related to defective or returned products at the time of sale based on its ability to estimate sales returns and allowances using historical information. For the three months ended October 31, 2014 and 2013, the Company calculated the amount to be less than 1% of sales so no allowance was accrued in either year. Shipping and handling fees and related freight costs and supplies associated with shipping products to customers are included as a component of cost of sales. Payments received before all of the relevant criteria for revenue recognition are satisfied are recorded as unearned revenue.
	The Company also recognizes revenues from the distribution of its product through trade partners. Related revenues consist of product costs, distribution fees, testing and labeling costs, as well as any associated administrative fees. The Company recognizes these revenues after the product has been shipped from the outsource manufacturer to the trade partner. The Company has contractual obligation to pay the outsource manufacturers, and as a principal in these arrangements the Company includes the total product price as revenue in accordance with applicable accounting guidance. The Company has separately negotiated contractual relationships with its trade partners, and under contracts with these trade partners the Company assumes the credit risk of product produced by the outsource manufacturer and dispensed to the trade partner.
	Unearned Revenues consist of cash received in advance for products to be delivered at a future date. The Company records the payments received as a liability until the products are delivered. The Company recorded unearned revenue of $262,084 and $338,263 as of October 31, 2014 and July 31, 2014, respectively.
	Cost of Sales
	The Company includes product costs (i.e. material, direct labor and overhead costs), shipping and handling expense, insurance on inventory, production-related depreciation expense and product license agreement expense in cost of sales.

COMMITMENTS_CONTINGENCIES_AND_

COMMITMENTS, CONTINGENCIES AND LEGAL MATTERS	3 Months Ended
	Oct. 31, 2014
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS, CONTINGENCIES AND LEGAL MATTERS	NOTE 3 – COMMITMENTS, CONTINGENCIES AND LEGAL MATTERS
	Management of the Company has conducted a diligent search and concluded that there were no commitments, contingencies, or legal matters pending at the balance sheet dates that have not been disclosed.

LEASES

LEASES	3 Months Ended
	Oct. 31, 2014
Leases [Abstract]
LEASES	NOTE 4 – LEASES
	The Company leases a 3,000 square foot office in the Draper, Utah that serves as its principal executive offices. The lease expires on December 31, 2014. Pursuant to the lease, the rent for the three months ended October 31, 2014 and 2013, totaled $12,920 and $12,676, respectively.
	The Company has three separate subleases for three rooms totaling 1,500 square feet of their Draper office space to three individuals on a month to month basis. The remaining two leases were terminated in September 2013 and October 2013. Pursuant to the sublease agreements, the monthly rent received for the three months ended October 31, 2014 and 2013 totaled $0 and $18,500, respectively.
	The Company leased certain machinery and equipment in 2013 and 2012 under an agreement that is classified as an operating lease. The lease expired on July 15, 2013, and is now leased on a month-to-month basis. Rent expense under the operating lease totaled $1,036 and $1,143 at for the three months ended October 31, 2014 and 2013, respectively.
	The future minimum lease payments required under the operating leases as of July 31, 2014, are as follows:
	Year Ended July 31,	Amount
	2015	$	6,750
	2016		-
	2017		-
	2018		-
	Thereafter		-
	Total lease obligations	$	6,750

RELATED_PARTY_NOTES_PAYABLE

RELATED PARTY NOTES PAYABLE	3 Months Ended
	Oct. 31, 2014
Related Party Notes Payable [Abstract]
RELATED PARTY NOTES PAYABLE	NOTE 5 – RELATED PARTY NOTES PAYABLE
	In January 2012, the Company entered into a two year, zero percent note with an 8% imputed interest rate with a director in the amount of $150,000. The note is due on December 31, 2014. The Company agreed to pay royalty payments in connection with sales of a certain product line. The Company paid royalty payments of $0 and $1,374 in the three months ended October 31, 2014 and 2013, respectively.
	As of October 31, 2014 and July 31, 2014, the Company owed a total of $35,036 and $36,608 in principal in related party notes. On December 12, 2014, the Company paid off the related party note payable, see note 14 below.

RELATED_PARTY_PAYABLE

RELATED PARTY PAYABLE	3 Months Ended
	Oct. 31, 2014
Related Party Transactions [Abstract]
RELATED PARTY PAYABLE	NOTE 6 – RELATED PARTY PAYABLE
	Related party payables consist of payments made by a director through credit cards and use of a line of credit related used to pay expenses on behalf of the Company. During the three months ended October 31, 2014 and 2013, the Company made payments of $974 and $1,023, respectively. As of October 31, 2014 and July 31, 2014, the Company owed a total of $20,109 and $21,083 in related party payables.

LINES_OF_CREDIT_AND_LOAN_PAYAB

LINES OF CREDIT AND LOAN PAYABLE	3 Months Ended
	Oct. 31, 2014
Lines Of Credit And Loan Payable [Abstract]
LINES OF CREDIT AND LOAN PAYABLE	NOTE 8 – LINES OF CREDIT AND LOAN PAYABLE
	The Company maintains a Line of Credit with Key Bank (the "Lender"). The Line of Credit was opened on August 28, 2012, with an available $250,000 to be drawn on for one year, not to exceed the principal amount ("draw period"). Once the draw period is completed, advances will no longer be permitted and the Company shall repay the principal and interest outstanding, over 5 years ("repayment period"). The repayment period begins August 28, 2013, after which a minimum monthly payment amount will be determined. The initial interest rate is 5.210%, and is variable. The variable interest rate is based on an independent index which is the "prime rate" as published each business day in the "Money Rates" column of the Wall Street Journal. Interest on the note is computed on a 365/365 simple interest basis, using 1.960% points over the index. The Lender executed a commercial security agreement. With this agreement, the Lender is entitled to a security interest in the Company's inventory, chattel paper, accounts receivable and general intangibles. In August 2013, the line of credit was converted into a note, and the Company is no longer able to borrow any additional funds. Under the new terms of the note, the note has a face value of $250,000 that matures on September 1, 2018, with an interest rate of prime plus 1.960%, and as of the date of the note, the interest rate was 5.21%. The note has minimum monthly payments of $4,745 which started on October 1, 2013. The balance outstanding on this note and line of credit as of October 31, 2014 and July 31, 2014, was $201,231 and $208,901, respectively. As of October 31, 2014, the Company has paid $48,769 in principal payments. The Lender allowed the Company to absorb a prior $50,000 note into the note, not affecting the repayment date. The Company did incur issuance costs of $4,037, which were expensed upon occurrence.
	Loans payable consisted of the following as of October 31, 2014 and July 31, 2014:
	Loan Payable
		October 31,			July 31,
		2014			2014
	$250,000 face value, converted from a LOC on August 28, 2013, interest rate of 5.21%, matures on September 1, 2018.		$	201,231		$	208,901
	$50,000 face value, issued on December 9, 2013, with no interest rate, matured and was paid in full on May 31, 2014.			-			-
	Total Loan payable			201,231			208,901
	Less current portion			52,426			51,071
	Loan payable, long-term		$	148,805		$	157,830
	In 1998, the Company entered into a line of credit with Zions Bank ("Lender") with a credit limit of $40,000. The line bears a compounding per annum fixed interest rate of 5.25%. As of October 31, 2014 and July 31, 2014, the Company owed $29,887 and $33,098 in principal, respectively. The Lender executed a commercial security agreement. With this agreement, the Lender is entitled to a security interest in the Company's inventory, chattel paper, accounts receivable and general intangibles. The Company did incur a setup fee, which has been fully amortized. There is no term limit on the line and the Company is allowed to draw up to its dollar limit.

CONVERTIBLE_NOTES_PAYABLE_AND_

CONVERTIBLE NOTES PAYABLE AND LOAN PAYABLE	3 Months Ended
	Oct. 31, 2014
Convertible Notes Payable And Loan Payable [Abstract]
CONVERTIBLE NOTES PAYABLE AND LOAN PAYABLE	NOTE 9 – CONVERTIBLE NOTES PAYABLE AND LOAN PAYABLE
	Convertible notes payable consisted of the following as of October 31, 2014 and July 31, 2014, respectively:
		October 31,		July 31,
		2014		2014
	$250,000 face value, issued on September 27, 2013, interest rate of 10%, matures on September 27, 2015.	$	250,000	$	250,000
	$125,000 face value, issued on October 18, 2013, interest rate of 10%, matures on October 18, 2015.		125,000		125,000
	$150,000 face value, issued on November 22, 2013, interest rate of 10%, matures on November 22, 2015.		150,000		150,000
	$78,500 face value, of which, $42,000 was converted, issued on January 14, 2014, interest rate of 8% and a default rate of 22%, matures on October 14, 2014, net of unamortized discount of $0 and $48,741 as of October 31, 2014 and July 31, 2014.		36,500		29,759
	$53,000 face value, issued on March 19, 2014, interest rate of 8%, matures on December 26, 2014, net of unamortized discount of $23,098 and $39,087 as of October 31, 2014 and July 31, 2014.		29,902		13,913
	$63,000 face value, issued on May 15, 2014, interest rate of 8%, matures on February 2, 2015, net of unamortized discount of $37,265 and $47,673 as of October 31, 2014 and July 31, 2014.		25,735		15,327
	Total convertible notes payable – non-related parties		617,137		583,999
	Less current portion		546,658		58,999
	Convertible notes payable, long-term	$	70,479	$	525,000
	On September 27, 2013, the Company issued a convertible note to an unrelated party for $250,000 that matures in September 27, 2015. The note bears an interest rate of 10% per annum with a floor of $.005 per share, and principal is convertible at any time after September 27, 2013 in part or in whole into shares of the Company's common stock using the average closing prices for five trading days directly preceding the conversion date. Interest is not convertible and is due upon conversion or at maturity date.
	On October 18, 2013, the Company issued a convertible note to an unrelated party for $125,000 that matures in October 18, 2015. The note bears an interest rate of 10% per annum with a floor of $.005 per share, and principal is convertible at any time after October 18, 2013 in part or in whole into shares of the Company's common stock using the average closing prices for five trading days directly preceding the conversion date. Interest is not convertible and is due upon conversion or at the maturity date.
	On November 22, 2013, the Company issued a convertible note to an unrelated party for $150,000 that matures in November 22, 2015. The note bears an interest rate of 10% per annum with a floor of $.005 per share, and principal is convertible at any time after November 22, 2013 in part or in whole into shares of the Company's common stock using the average closing prices for five trading days directly preceding the conversion date. Interest is not convertible and is due upon conversion or at the maturity date.
	On January 14, 2014, the Company entered into a convertible promissory note with Asher Enterprises, Inc. ("Asher") a Delaware corporation for an 8% convertible promissory note with an aggregate principal amount of $78,500 which together with any unpaid accrued interest is due on October 17, 2014. This convertible note together with any unpaid accrued interest is convertible into shares of common stock at the holder's option 180 days from inception at a variable conversion price calculated as 58% of the Market Price, which means the average of the lowest three Trading Prices (defined as the closing bid prices) during the ten trading day period ending on the last complete trading day prior to the conversion date with a floor of $.00005 as stated in the conversion feature. In January 2014, the Company received cash in the amount of $58,600, with the remaining $19,900 being used for legal and accounting fees. The Company analyzed the note on the issuance date on January 14, 2014. The Company determined that the variable conversion price and the floor exceeding the authorized number of shares results in the need for bifurcation into a separate derivative liability valued at fair market value. On January 14, 2014, the Company estimated the fair market value of the derivative liability associated with the bifurcated conversion feature to be $87,968 and a discount on the note of $78,500.
	On September 24, 2014, Asher converted $15,000 of principal related to the January 14, 2014, convertible note into 583,658 shares of the Company's common stock at $0.0257 per share.
	On October 2, 2014, Asher converted an additional $15,000 of principal related to the January 14, 2014, convertible note into 810,811 shares of the Company's common stock at $0.0185 per share.
	On October 9, 2014, Asher converted an additional $12,000 of principal related to the January 14, 2014, convertible note, into 869,565 shares of the Company's common stock at $0.0138 per share. The remaining principal balance due after the conversions was $36,500.
	On March 19, 2014, the Company entered into a convertible promissory note with KBM Worldwide, Inc. ("KBM") a New York corporation for an 8% convertible promissory note with an aggregate principal amount of $53,000 which together with any unpaid accrued interest is due on December 26, 2014. This convertible note together with any unpaid accrued interest is convertible into shares of common stock at the holder's option 180 days from inception at a variable conversion price calculated as 58% of the Market Price, which means the average of the lowest three Trading Prices (defined as the closing bid prices) during the three trading day period ending on the last complete trading day prior to the conversion date with a floor of $.00005 as stated in the conversion feature. In March 2014, the Company received cash in the amount of $24,487, with the remaining $6,898 being used for legal and accounting fees. The Company analyzed the note on the issuance date on January 14, 2014. The Company determined that the variable conversion price and the floor exceeding the authorized number of shares results in the need for bifurcation into a separate derivative liability valued at fair market value. On March 19, 2014, the Company estimated the fair market value of the derivative liability associated with the bifurcated conversion feature to be $47,806 and a discount on the note of $49,010.
	On May 15, 2014, the Company entered into a convertible promissory note with KBM Worldwide, Inc. ("KBM") a New York corporation for an 8% convertible promissory note with an aggregate principal amount of $63,000 which together with any unpaid accrued interest is due on February 2, 2015. This convertible note together with any unpaid accrued interest is convertible into shares of common stock at the holder's option 180 days from inception at a variable conversion price calculated as 58% of the Market Price, which means the average of the lowest three Trading Prices (defined as the closing bid prices) during the three trading day period ending on the last complete trading day prior to the conversion date with a floor of $.00005 as stated in the conversion feature. In May 2014, the Company received cash in the amount of $42,500, with the remaining $17,500 being used for legal fees. The Company analyzed the note on the issuance date on January 14, 2014. The Company determined that the variable conversion price and the floor exceeding the authorized number of shares results in the need for bifurcation into a separate derivative liability valued at fair market value. On May 15, 2014, the Company estimated the fair market value of the derivative liability associated with the bifurcated conversion feature to be $56,591 and a discount on the note of $56,591.
	As of October 31, 2014 and July 31, 2014, the Company estimated the fair market value of the derivative liability to be $139,409 and $177,907, with a change in fair value of $0, respectively. For the three months ended October 31, 2014 and 2013, the Company recorded $71,122 and $0 in amortization related to the discount on the note to interest expense and $4,016 and $0 in interest related to the three conversions of the Asher note. See note 12.

INCOME_TAXES

INCOME TAXES	3 Months Ended
	Oct. 31, 2014
Income Tax Disclosure [Abstract]
INCOME TAXES	NOTE 10 – INCOME TAXES
	The tax provision for interim periods is determined using an estimate of the Company's effective tax rate for the full year adjusted for discrete items, if any, that are taken into account in the relevant period. Each quarter the Company updates its estimate of the annual effective tax rate, and if the estimated tax rate changes, the Company makes a cumulative adjustment.
	At October 31, 2014 and July 31, 2014, the Company has a full valuation allowance against its deferred tax assets as it believes it is more likely than not that these benefits will not be realized.
	The Company files income tax returns in the U.S. federal tax jurisdiction and state of Utah tax jurisdiction. The tax year for 2014 remains open for federal and/or state tax jurisdictions.

STOCK_TRANSACTIONS

STOCK TRANSACTIONS	3 Months Ended
	Oct. 31, 2014
Stockholders' Equity Note [Abstract]
STOCK TRANSACTIONS	NOTE 11 – STOCK TRANSACTIONS
	As of October  31, 2014 and July 31, 2014, the Company has 750,000,000 shares of common stock authorized with a par value of $.001, and 54,023,354 and 51,151,766 shares of common stock issued and outstanding, respectively.
	During the three months ended October 31, 2014, the Company issued 607,554 shares of common stock as part of the Equity Purchase Agreement described below for cash for $37,990. The Company also issued 2,271,558 shares of common stock related to the three conversions of the Asher note for $42,000 in principal. The first conversion was for $15,000 of principal for 583,658 shares of the Company's common stock at $0.0257 per share, an additional $15,000 of principal was converted into 810,811 shares of the Company's common stock at $0.0185 per share, and the final conversion was for an additional $12,000 of principal into 869,565 shares of the Company's common stock at $0.0138 per share.
	During the three months ended October 31, 2013, the Company did not issue any shares of common stock.
	Equity Purchase Agreement
	The Company entered into an equity purchase agreement with Southridge Partners II, LP ("Southridge") on December 9, 2013. Pursuant to the Equity Purchase Agreement, Southridge committed to purchase up to $10,000,000 of the Company's common stock, over a period of time terminating on the earlier of: (i) 24 months from the effective date of a registration statement to be filed in connection therewith or (ii) the date on which Southridge has purchased shares of common stock pursuant to this agreement for an aggregate maximum purchase price of $10,000,000; such commitment is subject to certain conditions. The purchase price to be paid by Southridge will be 90% of the average of the lowest three (3) daily volume weighted average prices for the Company's common stock for the ten (10) trading days immediately following clearing of the Estimated Put Shares (defined below) (such purchase price the "Put Purchase Price") under the Equity Purchase Agreement.
	The Company will deliver to Southridge, simultaneously with delivery of a Put Notice, a number of Shares equal to 125% of the Investment Amount divided by the closing price of the Company's common stock on the day preceding the Put Notice date (the "Estimated Put Shares"). The actual number of Shares purchased by Southridge for the Investment Amount shall then be calculated by dividing the Investment Amount by the Put Purchase Price. Any excess Estimated Put Shares shall then be returned to the Company.
	The number of Shares sold to Southridge at any time shall not exceed the number of such shares that, when aggregated with all other shares of common stock of the Company then beneficially owned by Southridge, would result in Southridge owning more than 9.99% of all of the Company's common stock then outstanding. Also as part of the equity purchase agreement, the Company issued a promissory note to Southridge for $50,000, with 0% interest. This note matures on May 31, 2014 and is not convertible into common stock. Finally, as part of the equity purchase agreement, Southridge is prohibited from executing any short sales of the Company's common stock during the term of the equity purchase agreement.
	The Company will not be entitled to put shares to Southridge:
	·    unless there is an effective registration statement under the Securities Act to cover the resale of the shares by Southridge;
	·    unless the common stock continues to be quoted on the OTC Bulletin Board and has not been suspended from trading;
	·    if an injunction shall have been issued and remain in force, or action commenced by a governmental authority which has not been stayed or abandoned, prohibiting the purchase or the issuance of the shares to Southridge;
	·    if the Company has not complied with their obligations and are otherwise in breach of or in default under, the Equity Purchase Agreement, our registration rights agreement (the "Registration Rights Agreement") with Southridge or any other agreement executed in connection therewith with Southridge;
	·    since the date of the filing of the Company's most recent filing with the Securities and Exchange Commission no event that had or is reasonably likely to have a Material Adverse Effect (as defined in the Equity Purchase Agreement) has occurred; and
	·    to the extent that such shares would cause Southridge's beneficial ownership to exceed 9.99% of our outstanding shares.
	The Equity Purchase Agreement further provides that Southridge is entitled to customary indemnification from the Company for any losses or liabilities it suffers as a result of any breach of any provisions of the Equity Purchase Agreement or the Registration Rights Agreement, or as a result of any lawsuit brought by a third-party arising out of or resulting from Southridge's execution, delivery, performance or enforcement of the Equity Purchase Agreement or the Registration Rights Agreement or from material misstatements or omissions in the prospectus accompanying the registration statement for the resale of the shares issued to Southridge.
	As of October 31, 2014, 2,107,554 shares have been issued under the Equity Purchase Agreement.

DERIVATIVE_LIABILITY

DERIVATIVE LIABILITY	3 Months Ended
	Oct. 31, 2014
Derivative Liability [Abstract]
DERIVATIVE LIABILITY	NOTE 12 – DERIVATIVE LIABILITY
	FASB ASC 820 defines fair value, establishes a framework for measuring fair value under U.S. generally accepted accounting principles and enhances disclosures about fair value measurements. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value under FASB ASC 820 must maximize the use of observable inputs and minimize the use of unobservable inputs. The standard describes a fair value hierarchy based on three levels of inputs, with the first two inputs considered observable and the last input considered unobservable, that may be used to measure fair value as follows:
	·	Level one -- Quoted market prices in active markets for identical assets or liabilities;
	·	Level two – Inputs, other than level one inputs, that are either directly or indirectly observable; and
	·	Level three -- Unobservable inputs developed using estimates and assumptions, which are developed by the reporting entity and reflect those assumptions that a market participant would use.
	Determining which category an asset or liability falls within the hierarchy requires significant judgment. The Company evaluates its hierarchy disclosures each quarter. The Company has one liability measured at fair value on a recurring basis, which consists of a derivative liability on certain convertible notes payable (see note 11). As of October 31, 2014 this derivative liability had an estimated fair value of $139,409. The Company has no assets that are measured at fair value on a recurring basis.
	The following table presents information about our derivative liability, which was our only financial instrument measured at fair value on a recurring basis using significant inputs other than level one inputs that are either directly or indirectly observable (Level 2) as of October 31, 2014:
	Balance at July 31, 2014		$	177,907
	Conversions			(34,480	)
	Total (gains) losses included in earnings			(4,018	)
	Issuances			-
	Balance at July 31, 2014		$	139,409
	The fair value of this derivative liability was calculated using the multinomial lattice models that value the derivative liability within the notes based on a probability weighted discounted cash flow model. These models are based on future projections of the various potential outcomes. The features in the notes that were analyzed and incorporated into the model included the conversion feature with the reset provisions; redemption provisions; and the default provisions. Assumptions used to calculate the fair value of the derivative liability were as follows:
			July 31,
			2014
	Expected term in years		0-.26 years
	Risk-free interest rates			0.01-0.11	%
	Volatility			194 -202	%
	Dividend yield			0	%
	In addition to the assumptions above, the Company also takes into consideration whether or not the Company would participate in another round of financing and if that financing is registered or not and what that stock price would be for the financing at that time. The Company will continue to adjust the derivative liability for changes in fair value until the notes matured on October 14, 2014, and mature on December 26, 2014 and February 2, 2015.

INDUSTRY_SEGMENT_GEOGRAPHIC_IN

INDUSTRY SEGMENT, GEOGRAPHIC INFORMATION AND SIGNIFICANT CUSTOMERS	3 Months Ended
	Oct. 31, 2014
Segment Reporting [Abstract]
INDUSTRY SEGMENT, GEOGRAPHIC INFORMATION AND SIGNIFICANT CUSTOMERS	NOTE 13 – INDUSTRY SEGMENT, GEOGRAPHIC INFORMATION AND SIGNIFICANT CUSTOMERS
	Geographic Sales Regions
	We currently sell and distribute our products four geographic regions: North Asia, Greater China, South Asia/Pacific, Europe, Middle East, and Americas. The following table sets forth the revenue for each of the geographic regions for the three months ended October 31, 2014 and 2013:
		Periods Ended October 31,
		2014				2013
	Americas	$	363,088	56.62	%	$	690,753	87.06	%
	Europe		-	-			-	-
	Greater China		152,105	23.72			19,532	2.45
	Middle East		46	0.01			-	-
	North Asia		2,020	0.32			-	-
	South Asia/Pacific		123,978	19.33			83,211	10.49
		$	641,237	100	%	$	793,496	100	%
	The table below lists our equipment, net, by geographic area for the three months ended October 31, 2014 and 2013:
		Periods Ended October 31,
		2014				2013
	Americas	$	13,832	100	%	$	16,355	100	%
	Europe		-	-			-	-
	Greater China		-	-			-	-
	Middle East		-	-			-	-
	North Asia		-	-			-	-
	South Asia/Pacific		-	-			-	-
		$	13,832	100	%	$	16,355	100	%
	The table below lists revenue generated by each of the Company's product lines during the years ended three months ended October 31, 2014 and 2013:
		Periods Ended October 31,
		2014				2013
	Product Sales	$	634,661	98.97	%	$	784,711	98.89	%
	NBA Services		6,576	1.03			8,785	1.11
	Educational Services		-	-			-	-
		$	641,237	100	%	$	793,496	100	%
	Significant Customers
	Three of our customers make up approximately 37.57% of our total sales for three months ending October 31, 2014, as compared to one customer making up approximately 43.10% of our total sales for the same period in 2013.

SUBSEQUENT_EVENTS

SUBSEQUENT EVENTS	3 Months Ended
	Oct. 31, 2014
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	NOTE 14 – SUBSEQUENT EVENTS
	Management has evaluated subsequent events through December 19, 2014, which is the date the financial statements were available to be issued. The Company identified the following subsequent events through December 19, 2014:
	On November 14, 2014, Asher converted an additional $15,000 of principal related to the January 14, 2014, convertible note, into 931,677 shares of the Company's common stock at $0.0161 per share. The remaining principal balance due after the conversion was $21,500.
	On December 8, 2014, Asher converted an additional $12,500 of principal related to the January 14, 2014, convertible note, into 1,041,667 shares of the Company's common stock at $0.012 per share. The remaining principal balance due after the conversion was $9,000.
	On December 2, 2014, the Company entered into a collateralized secured convertible promissory note with LG Capital Funding, LLC ("LG"), a New York limited liability company, for an 8% convertible promissory note with an aggregate principal amount of $73,500, which together with any unpaid accrued interest is due on December 2, 2015. This convertible note together with any unpaid accrued interest is convertible into shares of common stock at the holder's option 180 days from inception at a variable conversion price calculated as 58% of the average of the lowest three closing bid prices during the ten trading day period ending on the conversion date. This note was funded on December 10, 2014, when the Company received cash in the amount of $70,000, with the remaining $3,500 being used for LG's legal and other origination expenses.  On December 2, 2014, the Company also entered into a second $73,500 convertible promissory note with LG on the same terms as the first note and due on December 2, 2015, which has not yet been funded.  This note is collateralized by a secured promissory note issued by LG to the Company for $73,500, due on August 2, 2015, and accruing interest at the rate of 8% per annum.
	On December 2, 2014, the Company entered into a collateralized secured convertible promissory note with Typenex Co-Investment, LLC ("Typenex"), a Utah limited liability company, for an 10% convertible promissory note with an aggregate principal amount of $224,000, of which the company is to assume $20,000 in original interest discount ("OID") and legal fees and other expenses of Typenex totaling $4,000, which together with any unpaid accrued interest is due on September 10, 2016. The note is to be issued in tranches with an initial tranche of $59,000, of which the company received $50,000 on December 10, 2014, with the remaining $4,000 being used for legal and other expenses of Typenex and the Company assuming $5,000 in OID. This convertible note together with any unpaid accrued interest is convertible into shares of common stock at a variable conversion price calculated as 58% of the average of the lowest three closing bid prices during the ten trading day period ending on the last complete trading day prior to the conversion date. The remaining three tranches of $55,000 of funding to the Company under the note will consist of $50,000 in principal and the $5,000 in OID, which have not yet been funded, and shall correspond to three $50,000 promissory notes issued by Typenex in favor of the Company, accruing interest at 8% per annum and maturing on September 2, 2016.
	In conjunction with the Company's convertible note issued to Typenex and Typenex's three promissory notes issued to the Company for the three additional tranches of funding to the Company, the Company issued four warrants for a total number of shares equal to $112,000 ($29,500 for the first warrant corresponding to funding on December 10, 2014, and $27,500 for the other three warrants corresponding to the future tranches of funding by Typenex to the Company) divided by the conversion market price in the Typenex convertible note. The warrants have an exercise price of $0.06, subject to adjustment, and expire on December 2, 2019. Each of the warrants are only exerciseable after the corresponding tranche of funding by Typenex to the company has been paid. Therefore, the first warrant is currently exerciseable, but the other three warrants are not.
	On December 2, 2014, the Company entered into a convertible promissory note with JMJ Financial, a Nevada sole proprietorship ("JMJ"), with a face amount of $350,000, of which the company is to assume $35,000 in original interest discount ("OID"), which together with any unpaid accrued interest is due on Dec 2, 2016.  The note is to be funded by JMJ at its discretion, and the initial tranche was funded on December 16, 2014, when the Company received cash in the amount of $55,000. The note balance funded (plus a pro rata portion of the OID) together with any unpaid accrued interest is convertible into shares of common stock at a variable conversion price calculated as 65% of the average of the lowest trade price during a 25-day period ending on the last complete trading day prior to the conversion date.
	On December 12, 2014, the Company settled its related party note payable in the amount of $35,036 with a Company director in exchange for $30,000 cash.

SUMMARY_OF_SIGNIFICANT_ACCOUNT1

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	3 Months Ended
	Oct. 31, 2014
Accounting Policies [Abstract]
Loss per Share	Loss per Share
	Basic loss per share ("EPS") is computed by dividing net loss (the numerator) by the weighted-average number of common shares outstanding for the period (the denominator). Diluted EPS is computed by dividing net loss by the weighted-average number of common shares and potential common shares outstanding (if dilutive) during each period. Potential common shares include common shares to be issued related to convertible debentures and stock pending issue under the ratchet provision.
	As the Company has incurred losses for the three months ended October 31, 2014 and 2013, the potentially dilutive shares are anti-dilutive and are thus not added into the loss per share calculations.
Going Concern	Going Concern
	The Company's financial statements are prepared using generally accepted accounting principles applicable to a going concern that contemplates the realization of assets and liquidation of liabilities in the normal course of business. The Company has generally had net losses after consideration of income taxes. Further, the Company has negative working capital and insufficient cash flows from operation as of October 31, 2014, and does not have the requisite liquidity to pay its current obligations. These factors, among others, raise substantial doubt about its ability to continue as a going concern. Management will seek to increase revenues and reduce costs, while raising capital through the sale of its stock. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.
Use of Estimates	Use of Estimates
	The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America ("US GAAP") requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. These estimates and assumptions are based on management's best estimates and judgment. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the economic environment, which management believes to be reasonable under the circumstances. Management adjusts such estimates and assumptions when facts and circumstances dictate. As future events and their effects cannot be determined with precision, actual results could differ from those estimates.
Derivative Liabilities	Derivative Liabilities
	In connection with the private placement of certain convertible notes beginning in January 2014, the Company became contingently obligated to issue shares of common stock in excess of the 750 million authorized under the Company's certificate of incorporation. Consequently, the ability to settle these obligations with common shares would be unavailable causing these obligations to potentially be settled in cash. This condition creates a derivative liability.
	The Company has a sequencing policy regarding share settlement wherein instruments with the earliest issuance date would be settled first. The sequencing policy also considers contingently issuable additional shares, such as those issuable upon a stock split, to have an issuance date to coincide with the event giving rise to the additional shares.
	Using this sequencing policy, all instruments convertible into common stock, including warrants and the conversion feature of notes payable, issued subsequent to January 14, 2014 are derivative liabilities.
	The Company values these convertible notes payable using the multinomial lattice method that values the derivative liability within the notes based on a probability weighted discounted cash flow model. The resulting liability is valued at each reporting date and the change in the liability is reflected as change in derivative liability in the statement of operations.
Revenue Recognition	Revenue Recognition
	Our revenue is derived from the service revenue from Live Blood Analysis, sale of retail products, and revenue derived from educational services.
	The Company's revenue recognition policy is in accordance with the requirements of Staff Accounting Bulletin ("SAB") No. 104, Revenue Recognition ("SAB 104"), and other applicable revenue recognition guidance under US GAAP. Sales revenue is recognized for our retail and wholesale customers when: (i) persuasive evidence of a sales arrangement exists, (ii) the sales terms are fixed or determinable, (iii) title and risk of loss have transferred, and (iv) collectability is reasonably assured — generally when products are shipped to the customer and services are rendered, except in situations in which title passes upon receipt of the products by the customer. In this case, revenues are recognized upon notification that customer receipt has occurred. The Company accrues an estimated amount for sales returns and allowances related to defective or returned products at the time of sale based on its ability to estimate sales returns and allowances using historical information. For the three months ended October 31, 2014 and 2013, the Company calculated the amount to be less than 1% of sales so no allowance was accrued in either year. Shipping and handling fees and related freight costs and supplies associated with shipping products to customers are included as a component of cost of sales. Payments received before all of the relevant criteria for revenue recognition are satisfied are recorded as unearned revenue.
	The Company also recognizes revenues from the distribution of its product through trade partners. Related revenues consist of product costs, distribution fees, testing and labeling costs, as well as any associated administrative fees. The Company recognizes these revenues after the product has been shipped from the outsource manufacturer to the trade partner. The Company has contractual obligation to pay the outsource manufacturers, and as a principal in these arrangements the Company includes the total product price as revenue in accordance with applicable accounting guidance. The Company has separately negotiated contractual relationships with its trade partners, and under contracts with these trade partners the Company assumes the credit risk of product produced by the outsource manufacturer and dispensed to the trade partner.
	Unearned Revenues consist of cash received in advance for products to be delivered at a future date. The Company records the payments received as a liability until the products are delivered. The Company recorded unearned revenue of $262,084 and $338,263 as of October 31, 2014 and July 31, 2014, respectively.
Cost of Sales	Cost of Sales
	The Company includes product costs (i.e. material, direct labor and overhead costs), shipping and handling expense, insurance on inventory, production-related depreciation expense and product license agreement expense in cost of sales.

LEASES_Tables

LEASES (Tables)	3 Months Ended
	Oct. 31, 2014
Leases [Abstract]
Schedule of future minimum lease payments required under the operating leases	Year Ended July 31,	Amount
	2015	$	6,750
	2016		-
	2017		-
	2018		-
	Thereafter		-
	Total lease obligations	$	6,750

LINES_OF_CREDIT_AND_LOAN_PAYAB1

LINES OF CREDIT AND LOAN PAYABLE (Tables)	3 Months Ended
	Oct. 31, 2014
Lines Of Credit And Loan Payable [Abstract]
Schedule of loan payable		October 31,			July 31,
		2014			2014
	$250,000 face value, converted from a LOC on August 28, 2013, interest rate of 5.21%, matures on September 1, 2018.		$	201,231		$	208,901
	$50,000 face value, issued on December 9, 2013, with no interest rate, matured and was paid in full on May 31, 2014.			-			-
	Total Loan payable			201,231			208,901
	Less current portion			52,426			51,071
	Loan payable, long-term		$	148,805		$	157,830

CONVERTIBLE_NOTES_PAYABLE_AND_1

CONVERTIBLE NOTES PAYABLE AND LOAN PAYABLE (Tables)	3 Months Ended
	Oct. 31, 2014
Convertible Notes Payable And Loan Payable [Abstract]
Schedule of convertible notes payable		October 31,		July 31,
		2014		2014
	$250,000 face value, issued on September 27, 2013, interest rate of 10%, matures on September 27, 2015.	$	250,000	$	250,000
	$125,000 face value, issued on October 18, 2013, interest rate of 10%, matures on October 18, 2015.		125,000		125,000
	$150,000 face value, issued on November 22, 2013, interest rate of 10%, matures on November 22, 2015.		150,000		150,000
	$78,500 face value, of which, $42,000 was converted, issued on January 14, 2014, interest rate of 8% and a default rate of 22%, matures on October 14, 2014, net of unamortized discount of $0 and $48,741 as of October 31, 2014 and July 31, 2014.		36,500		29,759
	$53,000 face value, issued on March 19, 2014, interest rate of 8%, matures on December 26, 2014, net of unamortized discount of $23,098 and $39,087 as of October 31, 2014 and July 31, 2014.		29,902		13,913
	$63,000 face value, issued on May 15, 2014, interest rate of 8%, matures on February 2, 2015, net of unamortized discount of $37,265 and $47,673 as of October 31, 2014 and July 31, 2014.		25,735		15,327
	Total convertible notes payable – non-related parties		617,137		583,999
	Less current portion		546,658		58,999
	Convertible notes payable, long-term	$	70,479	$	525,000

DERIVATIVE_LIABILITY_Tables

DERIVATIVE LIABILITY (Tables)	3 Months Ended
	Oct. 31, 2014
Derivative Liability [Abstract]
Schedule of financial instrument measured at fair value on a recurring basis using significant inputs other than level one inputs	Balance at July 31, 2014	$	177,907
	Conversions		(34,480	)
	Total (gains) losses included in earnings		(4,018	)
	Issuances		-
	Balance at July 31, 2014	$	139,409
Schedule of assumptions used to calculate the fair value of the derivative liability		July 31,
		2014
	Expected term in years	0-.26 years
	Risk-free interest rates		0.01-0.11	%
	Volatility		194 -202	%
	Dividend yield		0	%

INDUSTRY_SEGMENT_GEOGRAPHIC_IN1

INDUSTRY SEGMENT, GEOGRAPHIC INFORMATION AND SIGNIFICANT CUSTOMERS (Tables)	3 Months Ended
	Oct. 31, 2014
Segment Reporting [Abstract]
Schedule of revenue for each of geographic regions		Periods Ended October 31,
		2014				2013
	Americas	$	363,088	56.62	%	$	690,753	87.06	%
	Europe		-	-			-	-
	Greater China		152,105	23.72			19,532	2.45
	Middle East		46	0.01			-	-
	North Asia		2,020	0.32			-	-
	South Asia/Pacific		123,978	19.33			83,211	10.49
		$	641,237	100	%	$	793,496	100	%
Schedule of equipment, net, by geographic area		Periods Ended October 31,
		2014				2013
	Americas	$	13,832	100	%	$	16,355	100	%
	Europe		-	-			-	-
	Greater China		-	-			-	-
	Middle East		-	-			-	-
	North Asia		-	-			-	-
	South Asia/Pacific		-	-			-	-
		$	13,832	100	%	$	16,355	100	%
Schedule of revenue generated by each of product lines		Periods Ended October 31,
		2014				2013
	Product Sales	$	634,661	98.97	%	$	784,711	98.89	%
	NBA Services		6,576	1.03			8,785	1.11
	Educational Services		-	-			-	-
		$	641,237	100	%	$	793,496	100	%

ORGANIZATION_AND_BASIS_OF_PRES1

ORGANIZATION AND BASIS OF PRESENTATION (Detail Textuals)	3 Months Ended	0 Months Ended
	Oct. 31, 2014	Sep. 13, 2013	Jul. 31, 2014
	Country
Organization And Basis Of Presentation [Line Items]
Number of countries where company sells its products directly to public	16
Number of common shares issued	54,023,354		51,151,766
Number of common shares outstanding	54,023,354		51,151,766
Reverse Acquisition And Recapitalization | Share Exchange Agreement | Buka Ventures Inc
Organization And Basis Of Presentation [Line Items]
Number of shares cancelled		25,000,000
Number of common shares issued		46,500,000
Number of common shares outstanding		46,500,000
Number of common stock issued in exchange with Nutranomics		25,005,544
Reverse Acquisition And Recapitalization | Share Exchange Agreement | Health Education Corporation
Organization And Basis Of Presentation [Line Items]
Number of common stock shares received from Nutranomics		8,994,800

SUMMARY_OF_SIGNIFICANT_ACCOUNT2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Detail Textuals) (USD $)	3 Months Ended
	Oct. 31, 2014	Oct. 31, 2013	Jul. 31, 2014
Accounting Policies [Abstract]
Common stock, shares authorized	750,000,000		750,000,000
Unearned revenue	$262,084		$338,263
Percentage of return on sale description	less than 1% of sales	less than 1% of sales

LEASES_Details

LEASES (Details) (USD $)	Jul. 31, 2014
Year Ended July 31,
2015	$6,750
2016
2017
2018
Thereafter
Total lease obligations	$6,750

LEASES_Detail_Textuals

LEASES (Detail Textuals) (USD $)	3 Months Ended
	Oct. 31, 2014	Oct. 31, 2013
	Sublease
	sqft
Leases [Line Items]
Area of office (in square foot)	3,000
Expiry date of lease	31-Dec-14
Rent expenses	$12,920	$12,676
Number of subleases	3
Area of subleased property (in Square feet)	1,500
Number of subleases terminated	2
Date of termination of first subleased property	Sep-13
Date of termination of second subleased property	Oct-13
Rent received	0	18,500
Machinery and equipment
Leases [Line Items]
Expiry date of lease	15-Jul-13
Rent expenses	$1,036	$1,143

RELATED_PARTY_NOTES_PAYABLE_De

RELATED PARTY NOTES PAYABLE (Detail Textuals) (USD $)	3 Months Ended		1 Months Ended
	Oct. 31, 2014	Oct. 31, 2013	Jan. 31, 2012	Jul. 31, 2014
Debt Instrument [Line Items]
Royalty payments	$0	$1,374
Amount of principal in related party notes payable	35,036			36,608
Notes payable | Director
Debt Instrument [Line Items]
Maturity period of note payable			2 years
Percentage of interest rate on note payable			0.00%
Percentage of imputed interest rate on note payable			8.00%
Note payable			$150,000
Maturity date of note payable			31-Dec-14

RELATED_PARTY_PAYABLE_Detail_T

RELATED PARTY PAYABLE (Detail Textuals) (USD $)	3 Months Ended
	Oct. 31, 2014	Oct. 31, 2013	Jul. 31, 2014
Related Party Transaction [Line Items]
Due to related parties	$20,109		$21,083
Director
Related Party Transaction [Line Items]
Repayment made by the company	$974	$1,023

LINES_OF_CREDIT_AND_LOAN_PAYAB2

LINES OF CREDIT AND LOAN PAYABLE (Details) (USD $)	Oct. 31, 2014	Jul. 31, 2014
Debt Instrument [Line Items]
Total Loan payable	$201,231	$208,901
Less current portion	52,426	51,071
Loan payable, long-term	148,805	157,830
$250,000 face value, converted from a LOC on August 28, 2013, interest rate of 5.21%, matures on September 1, 2018.
Debt Instrument [Line Items]
Total Loan payable	201,231	208,901
$50,000 face value, issued on December 9, 2013, with no interest rate, matured and was paid in full on May 31, 2014.
Debt Instrument [Line Items]
Total Loan payable

LINES_OF_CREDIT_AND_LOAN_PAYAB3

LINES OF CREDIT AND LOAN PAYABLE (Detail Textuals) (USD $)	0 Months Ended	1 Months Ended
	Dec. 09, 2013	Aug. 28, 2013	Aug. 28, 2012	Jul. 31, 1998	Oct. 31, 2014	Jul. 31, 2014
Line of Credit Facility [Line Items]
Note payable					$201,231	$208,901
Lines of credit, current					29,887	33,098
Promissory Note | Equity Purchase Agreement | Southridge Partners II, LP ("Southridge")
Line of Credit Facility [Line Items]
Face amount of note payable	50,000
Maturity date of note payable	31-May-14
Percentage of interest rate on note payable	0.00%
Loans Payable
Line of Credit Facility [Line Items]
Line of credit facility, repayment period		5 years
Debt instrument basis spread on variable rate		1.96%
Face amount of note payable		250,000
Maturity date of note payable		1-Sep-18
Percentage of interest rate on note payable		5.21%
Note payable, minimum monthly payments		4,745
Note payable, frequency of minimum monthly payments		monthly
Note payable					201,231	208,901
Loan payable paid in principal payment					48,769
Note payable, allowable portion to be absorbed		50,000
Note payable, issuance cost		4,037
Key Bank | Line of Credit
Line of Credit Facility [Line Items]
Line of credit facility, amount			250,000
Line of credit, initial interest rate			5.21%
Zions Bank | Line of Credit
Line of Credit Facility [Line Items]
Line of credit facility, amount				$40,000
Line of credit, initial interest rate				5.25%

CONVERTIBLE_NOTES_PAYABLE_AND_2

CONVERTIBLE NOTES PAYABLE AND LOAN PAYABLE (Details) (USD $)	Oct. 31, 2014	Jul. 31, 2014
Debt Instrument [Line Items]
Less current portion	$546,658	$58,999
Convertible notes payable, long-term	70,479	525,000
Convertible notes payable
Debt Instrument [Line Items]
Total convertible notes payable - non-related parties	617,137	583,999
Less current portion	546,658	58,999
Convertible notes payable, long-term	70,479	525,000
Convertible notes payable | Convertible notes payable matures on September 27, 2015
Debt Instrument [Line Items]
Total convertible notes payable - non-related parties	250,000	250,000
Convertible notes payable | Convertible notes payable matures on October 18, 2015
Debt Instrument [Line Items]
Total convertible notes payable - non-related parties	125,000	125,000
Convertible notes payable | Convertible notes payable matures on November 22, 2015
Debt Instrument [Line Items]
Total convertible notes payable - non-related parties	150,000	150,000
Convertible notes payable | Convertible notes payable matures on October 14, 2014
Debt Instrument [Line Items]
Total convertible notes payable - non-related parties	36,500	29,759
Convertible notes payable | Convertible notes payable matures on December 26, 2014
Debt Instrument [Line Items]
Total convertible notes payable - non-related parties	29,902	13,913
Convertible notes payable | Convertible notes payable matures On 2 February 2015
Debt Instrument [Line Items]
Total convertible notes payable - non-related parties	$25,735	$15,327

CONVERTIBLE_NOTES_PAYABLE_AND_3

CONVERTIBLE NOTES PAYABLE AND LOAN PAYABLE (Detail Textuals) (Convertible notes payable, Unrelated party, USD $)	3 Months Ended
	Oct. 31, 2014	Jul. 31, 2014
Convertible notes payable matures on September 27, 2015
Debt Instrument [Line Items]
Note payable	$250,000
Maturity date of convertible note	27-Sep-15
Interest rate of convertible note	10.00%
Floor price of convertible note	$0.01
Number of threshold trading days	5
Convertible notes payable matures on October 18, 2015
Debt Instrument [Line Items]
Note payable	125,000
Maturity date of convertible note	18-Oct-15
Interest rate of convertible note	10.00%
Floor price of convertible note	$0.01
Number of threshold trading days	5
Convertible notes payable matures on November 22, 2015
Debt Instrument [Line Items]
Note payable	150,000
Maturity date of convertible note	22-Nov-15
Interest rate of convertible note	10.00%
Floor price of convertible note	$0.01
Number of threshold trading days	5
Convertible notes payable matures on October 14, 2014
Debt Instrument [Line Items]
Note payable	78,500
Debt conversion amount	42,000
Maturity date of convertible note	14-Oct-14
Interest rate of convertible note	8.00%
Default rate of convertible note	22.00%
Unamortized discount	0	48,741
Convertible notes payable matures on December 26, 2014
Debt Instrument [Line Items]
Note payable	53,000
Maturity date of convertible note	26-Dec-14
Interest rate of convertible note	8.00%
Unamortized discount	23,098	39,087
Convertible notes payable matures On 2 February 2015
Debt Instrument [Line Items]
Note payable	63,000
Maturity date of convertible note	2-Feb-15
Interest rate of convertible note	8.00%
Unamortized discount	$37,265	$47,673

CONVERTIBLE_NOTES_PAYABLE_AND_4

CONVERTIBLE NOTES PAYABLE AND LOAN PAYABLE (Detail Textuals 1) (USD $)	3 Months Ended	12 Months Ended	0 Months Ended		1 Months Ended	0 Months Ended		1 Months Ended
	Oct. 31, 2014	Jul. 31, 2014	Oct. 02, 2014	Oct. 09, 2014	Sep. 24, 2014	Jan. 14, 2014	15-May-14	Mar. 19, 2014
Debt Instrument [Line Items]
Purchases of financial instrument classified as a derivative asset (liability)	($34,480)
Fair value of financial instrument classified as derivative asset (liability)	139,409	177,907
Change in fair value of derivative liability	0	0
Amortization of debt discount	75,138	0
Convertible notes payable | Asher Enterprises, Inc. ("Asher")
Debt Instrument [Line Items]
Percentage of interest rate on note payable						8.00%
Face amount of note payable			15,000	12,000	15,000	78,500
Percentage of common stock price to conversion price						58.00%
Price of the entity's common stock which would be required to be attained for the conversion						$0.00
Principal payments made during the period						58,600
Legal and accounting fees						19,900
Purchases of financial instrument classified as a derivative asset (liability)						87,968
Unamortized discount						78,500
Amortization of debt discount	71,122	0
Amortization Of Interest Expenses On Conversion	4,016	0
Convertible note shares			810,811	869,565	583,658
Common stock convertible conversion per share			$0.02	$0.01	$0.03
Remaining principal balance				36,500
Convertible notes payable | KBM Worldwide, Inc. ("KBM")
Debt Instrument [Line Items]
Percentage of interest rate on note payable							8.00%	8.00%
Face amount of note payable							63,000	53,000
Percentage of common stock price to conversion price							58.00%	58.00%
Price of the entity's common stock which would be required to be attained for the conversion							$0.00	$0.00
Principal payments made during the period							42,500	24,487
Legal and accounting fees							17,500	6,898
Purchases of financial instrument classified as a derivative asset (liability)							56,591	47,806
Unamortized discount							$56,591	$49,010

STOCK_TRANSACTIONS_Detail_Text

STOCK TRANSACTIONS (Detail Textuals) (USD $)	Oct. 31, 2014	Jul. 31, 2014
Stockholders' Equity Note [Abstract]
Common stock, shares authorized	750,000,000	750,000,000
Common stock, par value (in dollars per share)	$0.00	$0.00
Common stock, shares issued	54,023,354	51,151,766
Common stock, shares outstanding	54,023,354	51,151,766

STOCK_TRANSACTIONS_Detail_Text1

STOCK TRANSACTIONS (Detail Textuals 1) (USD $)	3 Months Ended
	Oct. 31, 2014
Stock Transactions [Line Items]
Total number of shares under agreement	2,107,554
Equity Purchase Agreement
Stock Transactions [Line Items]
Number of common stock issued under agreement for cash	607,554
value of common stock issued under agreement	37,990
Equity Purchase Agreement | Asher Enterprises, Inc. ("Asher")
Stock Transactions [Line Items]
Total number of shares under agreement	2,271,558
Amount of note for conversion	42,000
Equity Purchase Agreement | Asher Enterprises, Inc. ("Asher") | Debt Conversion One
Stock Transactions [Line Items]
Total number of shares under agreement	583,658
Amount of note for conversion	15,000
Conversion price per share	0.0257
Equity Purchase Agreement | Asher Enterprises, Inc. ("Asher") | Debt Conversion Two
Stock Transactions [Line Items]
Total number of shares under agreement	810,811
Amount of note for conversion	15,000
Conversion price per share	0.0185
Equity Purchase Agreement | Asher Enterprises, Inc. ("Asher") | Debt Conversion Three
Stock Transactions [Line Items]
Total number of shares under agreement	869,565
Amount of note for conversion	12,000
Conversion price per share	0.0138

STOCK_TRANSACTIONS_Detail_Text2

STOCK TRANSACTIONS (Detail Textuals 2) (Equity Purchase Agreement, Southridge Partners II, LP ("Southridge"), USD $)	0 Months Ended
	Dec. 09, 2013
	Day
Stock Transactions [Line Items]
Maximum issued amount of common stock	$10,000,000
Term of agreement	24 months
Put notice description	The Company will deliver to Southridge, simultaneously with delivery of a Put Notice, a number of Shares equal to 125% of the Investment Amount divided by the closing price of the Company's common stock on the day preceding the Put Notice date (the "Estimated Put Shares").
Number of daily volume weighted average prices	3
Number of trading days	10 days
Minimum percentage of common stock sold	90.00%
Equity purchase agreement, condition	(i) 24 months from the effective date of a registration statement to be filed in connection therewith or (ii) the date on which Southridge has purchased shares of common stock pursuant to this agreement for an aggregate maximum purchase price of $10,000,000; such commitment is subject to certain conditions. The purchase price to be paid by Southridge will be 90% of the average of the lowest three (3) daily volume weighted average prices for the Company's common stock for the ten (10) trading days immediately following clearing of the Estimated Put Shares (defined below) (such purchase price the "Put Purchase Price") under the Equity Purchase Agreement.
Promissory Note
Stock Transactions [Line Items]
Minimum percentage of common stock sold	9.99%
Principal amount of convertible note	$50,000
Interest paid on agreement	0.00%
Maturity date of note payable	31-May-14

DERIVATIVE_LIABILITY_Details

DERIVATIVE LIABILITY (Details) (USD $)	3 Months Ended	12 Months Ended
	Oct. 31, 2014	Jul. 31, 2014
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]
Balance at July 31, 2014	$177,907
Conversions	-34,480
Total (gains) losses included in earnings	-4,018	0
Issuances
Balance at July 31, 2014	$139,409	$177,907

DERIVATIVE_LIABILITY_Detail_1

DERIVATIVE LIABILITY (Detail 1)	12 Months Ended
	Jul. 31, 2014
Derivatives, Fair Value [Line Items]
Dividend yield	0.00%
Minimum
Derivatives, Fair Value [Line Items]
Expected term in years	0 days
Risk-free interest rates	0.01%
Volatility	194.00%
Maximum
Derivatives, Fair Value [Line Items]
Expected term in years	3 months 4 days
Risk-free interest rates	0.11%
Volatility	202.00%

DERIVATIVE_LIABILITY_Detail_Te

DERIVATIVE LIABILITY (Detail Textuals) (USD $)	Oct. 31, 2014
Derivative Liability [Abstract]
Fair value of financial instrument classified as derivative asset (liability)	$139,409

INDUSTRY_SEGMENT_GEOGRAPHIC_IN2

INDUSTRY SEGMENT, GEOGRAPHIC INFORMATION AND SIGNIFICANT CUSTOMERS (Details) (USD $)	3 Months Ended
	Oct. 31, 2014	Oct. 31, 2013
Segment Reporting Information [Line Items]
Revenue	$641,237	$793,496
Revenue
Segment Reporting Information [Line Items]
Revenue	641,237	793,496
Concentration risk, percentage	100.00%	100.00%
Americas | Revenue
Segment Reporting Information [Line Items]
Revenue	363,088	690,753
Concentration risk, percentage	56.62%	87.06%
Europe | Revenue
Segment Reporting Information [Line Items]
Revenue
Concentration risk, percentage
Greater China | Revenue
Segment Reporting Information [Line Items]
Revenue	152,105	19,532
Concentration risk, percentage	23.72%	2.45%
Middle East | Revenue
Segment Reporting Information [Line Items]
Revenue	46
Concentration risk, percentage	0.01%
North Asia | Revenue
Segment Reporting Information [Line Items]
Revenue	2,020
Concentration risk, percentage	0.32%
South Asia/Pacific | Revenue
Segment Reporting Information [Line Items]
Revenue	$123,978	$83,211
Concentration risk, percentage	19.33%	10.49%

INDUSTRY_SEGMENT_GEOGRAPHIC_IN3

INDUSTRY SEGMENT, GEOGRAPHIC INFORMATION AND SIGNIFICANT CUSTOMERS (Details 1) (USD $)	3 Months Ended
	Oct. 31, 2014	Oct. 31, 2013	Jul. 31, 2014
Segment Reporting Information [Line Items]
Equipment	$13,832		$16,355
Equipment
Segment Reporting Information [Line Items]
Equipment	13,832	16,355
Concentration risk, percentage	100.00%	100.00%
Americas | Equipment
Segment Reporting Information [Line Items]
Equipment	13,832	16,355
Concentration risk, percentage	100.00%	100.00%
Europe | Equipment
Segment Reporting Information [Line Items]
Equipment
Concentration risk, percentage
Greater China | Equipment
Segment Reporting Information [Line Items]
Equipment
Concentration risk, percentage
Middle East | Equipment
Segment Reporting Information [Line Items]
Equipment
Concentration risk, percentage
North Asia | Equipment
Segment Reporting Information [Line Items]
Equipment
Concentration risk, percentage
South Asia/Pacific | Equipment
Segment Reporting Information [Line Items]
Equipment
Concentration risk, percentage

INDUSTRY_SEGMENT_GEOGRAPHIC_IN4

INDUSTRY SEGMENT, GEOGRAPHIC INFORMATION AND SIGNIFICANT CUSTOMERS (Details 2) (USD $)	3 Months Ended
	Oct. 31, 2014	Oct. 31, 2013
Segment Reporting Information [Line Items]
Revenue	$641,237	$793,496
Revenue
Segment Reporting Information [Line Items]
Revenue	641,237	793,496
Concentration risk, percentage	100.00%	100.00%
Product Sales | Revenue
Segment Reporting Information [Line Items]
Revenue	634,661	784,711
Concentration risk, percentage	98.97%	98.89%
NBA Services | Revenue
Segment Reporting Information [Line Items]
Revenue	6,576	8,785
Concentration risk, percentage	1.03%	1.11%
Educational Services | Revenue
Segment Reporting Information [Line Items]
Revenue
Concentration risk, percentage

INDUSTRY_SEGMENT_GEOGRAPHIC_IN5

INDUSTRY SEGMENT, GEOGRAPHIC INFORMATION AND SIGNIFICANT CUSTOMERS (Detail Textuals)	3 Months Ended
	Oct. 31, 2014	Oct. 31, 2013
Segment Reporting Information [Line Items]
Number of geographic regions	4
Revenue
Segment Reporting Information [Line Items]
Percentage of total sales by single customer	100.00%	100.00%
Revenue | Customer Concentration Risk
Segment Reporting Information [Line Items]
Number of customers	3	1
Percentage of total sales by single customer	37.57%	43.10%

SUBSEQUENT_EVENTS_Detail_Textu

SUBSEQUENT EVENTS (Detail Textuals) (USD $)	3 Months Ended	0 Months Ended
	Oct. 31, 2014	Dec. 08, 2014	Nov. 14, 2014
Subsequent Event [Line Items]
Number converted in common shares	2,107,554
Subsequent Event | Asher Enterprises, Inc. ("Asher")
Subsequent Event [Line Items]
Amount of convertible note for conversion		$12,500	$15,000
Number converted in common shares		1,041,667	931,677
Conversion price per share		$0.01	$0.02
Remaining principal amount		$9,000	$21,500

SUBSEQUENT_EVENTS_Detail_Textu1

SUBSEQUENT EVENTS (Detail Textuals 1) (USD $)	3 Months Ended	0 Months Ended
	Oct. 31, 2013	Dec. 02, 2014
Subsequent Event [Line Items]
Cash received from convertible note	$375,000
Subsequent Event | LG Capital Funding, LLC | 8% Convertible Promissory Note
Subsequent Event [Line Items]
Interest rate of convertible note		8.00%
Principal amount of convertible note		73,500
Number of days unpaid accrued interest		180 days
Conversion price average of the lowest three closing bid prices		58.00%
Trading days		10 days
Cash received from convertible note		70,000
Legal and other origination expenses		3,500
Additional convertible note		$73,500

SUBSEQUENT_EVENTS_Detail_Textu2

SUBSEQUENT EVENTS (Detail Textuals 2) (Subsequent Event, 10% convertible promissory note, USD $)	0 Months Ended
	Dec. 02, 2014
Typenex Co-Investment, LLC ("Typenex")
Subsequent Event [Line Items]
Interest rate of convertible note	10.00%
Principal amount of convertible note	$224,000
Amount of original interest discount	20,000
Legal fees and other expenses	4,000
Amount of initial tranche	59,000
Original interest discount included in discount	5,000
Trading days	10 days
Conversion price average of the lowest three closing bid prices	58.00%
Amount of principal and original interest discount	55,000
Principal amount of remaining tranche	50,000
Interest amount of remaining tranche	5,000
Number of warrants issued (in shares)	4
Value of shares issued for warrants	112,000
Amount Of Warrants Initially Issued	29,500
Amount Of Warrants Issued Thereafter	27,500
Exercise price of warrants (in dollars per share)	$0.06
JMJ Financial
Subsequent Event [Line Items]
Principal amount of convertible note	350,000
Amount of original interest discount	35,000
Amount of initial tranche	$55,000
Trading days	25 days
Conversion price average of the lowest three closing bid prices	65.00%

SUBSEQUENT_EVENTS_Detail_Textu3

SUBSEQUENT EVENTS (Detail Textuals 3) (USD $)	3 Months Ended		0 Months Ended
	Oct. 31, 2014	Oct. 31, 2013	Dec. 12, 2014
Subsequent Event [Line Items]
Amount of note payable exchange for cash	$974	$825
Subsequent Event | Director
Subsequent Event [Line Items]
Amount of note payable			35,036
Amount of note payable exchange for cash			$30,000